Table 3. DALY estimates for CHIKV.
| YLLacute | YLDacute | YLDchronic | TOTAL* | |
|---|---|---|---|---|
| AFRO | 64 (0–2,548) |
10 (0–14) |
814 (1–74,360) |
888 (1–75,637) |
| AMRO | 6,592 (312–275,704) |
1,089 (5–1,457) |
87,314 (401–7,977,910) |
94,995 (767–8,111,092) |
| EMRO | 32 (0–1,820) |
7 (0–10) |
580 (16–52,960) |
619 (18–53,833) |
| EURO | 0 (0–52) |
0 (0–2) |
9 (0–840) |
9 (0–865) |
| SEARO | 544 (0–22,308) |
88 (0–118) |
7,066 (7–645,676) |
7,699 (8–656,457) |
| WPRO | 128 (0–5,460) |
22 (0–29) |
1,729 (0–158,012) |
1,879 (0–160,658) |
| TOTAL* | 7,360 (312–307,892) |
1,216 (5–1,627) |
97,513 (424–8,909,812) |
106,089 (794–9,058,541) |
AFRO, WHO Africa region; AMRO, WHO Americas region; CHIKV, chikungunya virus; DALY, disability-adjusted life year; EMRO, WHO Eastern Mediterranean region; EURO, WHO European region; SEARO, WHO Southeast Asia region; WPRO, Western Pacific region; YLD, years lost to disability; YLL, years of life lost.
*Note: Total DALY min. and max. values do not sum across rows because gains in 1 DALY category column are necessarily offset by reductions in other categories.